Clinical and body composition predictors of bone turnover and mineral content in obese postmenopausal women.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 22 08 2018
accepted: 15 10 2018
revised: 04 10 2018
pubmed: 21 10 2018
medline: 14 6 2019
entrez: 21 10 2018
Statut: ppublish

Résumé

The purpose of this study was to determine the predictors of bone mineral density (BMD), bone mineral content (BMC), and bone turnover markers in obese postmenopausal women. In this cross-sectional study, 81 postmenopausal women aged 58.40 ± 6.08 years were analyzed. Anthropometric parameters were recorded. Serum glucose parameters, serum lipid profiles, adipokines, renal, hepatic parameters, and bone markers concentrations were determined by well-validated laboratory routine methods. BMD, BMC, and body composition were measured by Dual X-ray Absorptiometry. We found a significant correlation of BMD with age, years since menopause, anthropometric parameters, glycemia, alkaline phosphatase, fat mass, and lean mass. Multiple regression analysis demonstrated that years since menopause, waist circumference, alkaline phosphatase, trunk fat, and lean mass were independently associated to BMD. Also, age, years since menopause, anthropometric parameters, total cholesterol, alkaline phosphatase, fat mass, and lean mass were correlated to BMC. However, only waist circumference and trunk fat were independently related to BMC. Bone turnover markers were significantly correlated to the age, glycemia, HbA1c, adipokines, hepatic parameters, and lean mass. Nevertheless, only adipokines, gamma glutamyl transferase (GGT), and alkaline phosphatase were independently associated to bone turnover markers. These observations suggest that number of years since menopause, waist circumference, alkaline phosphatase, trunk fat, and lean mass were the only significant predictors of BMD. However, waist circumference seems to be a stronger predictor than trunk fat for BMC. Moreover, adiponectin, resistin, GGT, and alkaline phosphatase were significant predictors of the bone resorption (CTX-I) and the bone formation (P1NP) markers.

Identifiants

pubmed: 30341704
doi: 10.1007/s10067-018-4343-4
pii: 10.1007/s10067-018-4343-4
doi:

Substances chimiques

Adipokines 0
Adiponectin 0
Blood Glucose 0
Collagen Type I 0
Glycated Hemoglobin A 0
Peptide Fragments 0
Procollagen 0
Resistin 0
hemoglobin A1c protein, human 0
procollagen Type I N-terminal peptide 0
Cholesterol 97C5T2UQ7J
gamma-Glutamyltransferase EC 2.3.2.2
Alkaline Phosphatase EC 3.1.3.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

739-747

Références

Maturitas. 2000 Mar 31;34(3):261-6
pubmed: 10717492
Diabetes Res Clin Pract. 2000 Jun;48(3):185-91
pubmed: 10802157
JAMA. 2001 Aug 15;286(7):791-2
pubmed: 11497531
Calcif Tissue Int. 2001 Jun;68(6):330-6
pubmed: 11685419
N Engl J Med. 1976 Jan 29;294(5):241-5
pubmed: 1244549
Bone. 2002 Nov;31(5):547-55
pubmed: 12477567
J Bone Miner Metab. 2003;21(1):17-21
pubmed: 12491089
Med Clin North Am. 2003 Sep;87(5):1039-63
pubmed: 14621330
Eur J Epidemiol. 2004;19(12):1105-12
pubmed: 15678790
J Bone Miner Res. 1992 Mar;7(3):253-61
pubmed: 1585826
Horm Metab Res. 2005 May;37(5):297-302
pubmed: 15971153
Bone. 2005 Oct;37(4):474-81
pubmed: 16040285
Osteoporos Int. 2005 Dec;16(12):1975-81
pubmed: 16167087
J Clin Endocrinol Metab. 1992 Jul;75(1):45-51
pubmed: 1619030
Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E735-45
pubmed: 16215165
J Cell Biochem. 2006 Oct 15;99(3):824-34
pubmed: 16721825
Osteoporos Int. 2008 Nov;19(11):1567-77
pubmed: 18414964
Osteoporos Int. 2010 Feb;21(2):195-214
pubmed: 19760059
Int J Clin Pract. 2010 May;64(6):817-20
pubmed: 20518955
Yonsei Med J. 2010 Nov;51(6):857-63
pubmed: 20879051
Arch Gerontol Geriatr. 2011 Sep-Oct;53(2):e192-7
pubmed: 20880598
Maturitas. 2011 May;69(1):86-90
pubmed: 21388758
Maedica (Buchar). 2010 Jan;5(1):24-7
pubmed: 21977114
Menopause. 2012 Apr;19(4):448-55
pubmed: 22251870
J Clin Densitom. 2012 Apr-Jun;15(2):186-90
pubmed: 22321655
Rheumatol Int. 2013 Mar;33(3):607-12
pubmed: 22481215
J Bone Miner Res. 2014 Apr;29(4):787-95
pubmed: 24123088
Arch Osteoporos. 2014;9:175
pubmed: 24664472
Ther Adv Endocrinol Metab. 2015 Dec;6(6):273-86
pubmed: 26623005
Endocrinol Metab (Seoul). 2016 Mar;31(1):64-71
pubmed: 26676328
J Transl Med. 2016 Jan 13;14:11
pubmed: 26791408
Clin Interv Aging. 2016 Jul 04;11:887-95
pubmed: 27445467
Osteoporos Int. 2017 Sep;28(9):2541-2556
pubmed: 28631236
J Clin Densitom. 2018 Apr - Jun;21(2):163-171
pubmed: 28687244
Biores Open Access. 2017 Jul 01;6(1):85-93
pubmed: 28736691
Bone Miner. 1987 May;2(3):211-9
pubmed: 3504732
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Osteoporos Int. 1994 Nov;4(6):362-7
pubmed: 7696834
Ann Intern Med. 1995 Mar 15;122(6):409-14
pubmed: 7856988
J Bone Miner Res. 1996 Jun;11(6):857-63
pubmed: 8725184

Auteurs

Rim Cherif (R)

UR11ES33, Research Unit Integrated Physiology, Laboratory of Biochemistry and Human Nutrition, Faculty of Sciences of Bizerte, Carthage University, 7021 Jarzouna, Tunis, Tunisia. cherifrim17@yahoo.fr.

Feten Mahjoub (F)

Department of Diabetology, National Institute of Nutrition, Tunis, Tunisia.

Hela Sahli (H)

Immuno-Rheumatology Laboratory, Rabta Hospital, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Elhem Cheour (E)

Immuno-Rheumatology Laboratory, Rabta Hospital, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Mohsen Sakly (M)

UR11ES33, Research Unit Integrated Physiology, Laboratory of Biochemistry and Human Nutrition, Faculty of Sciences of Bizerte, Carthage University, 7021 Jarzouna, Tunis, Tunisia.

Nebil Attia (N)

UR11ES33, Research Unit Integrated Physiology, Laboratory of Biochemistry and Human Nutrition, Faculty of Sciences of Bizerte, Carthage University, 7021 Jarzouna, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH